Kent summers (17 Ergebnisse)

- Softcover
Anbieter: ThriftBooks-Dallas, Dallas, TX, USAThriftBooks-Dallas
Verkäufer/-in kontaktierenVerkäufer/-in mit 5 SternenZustand: Gebraucht - Wie neu
EUR 8,19
Versand gratisVersand innerhalb von USAAnzahl: 1 verfügbar
Unknown. Zustand: As New. No Jacket. Pages are clean and are not marred by notes or folds of any kind. ~ ThriftBooks: Read More, Spend Less.

- Softcover
Anbieter: Better World Books, Mishawaka, IN, USABetter World Books
Verkäufer/-in kontaktierenVerkäufer/-in mit 5 SternenZustand: Gebraucht - Befriedigend
EUR 8,29
Versand gratisVersand innerhalb von USAAnzahl: 2 verfügbar
Zustand: Good. Pages intact with minimal writing/highlighting. The binding may be loose and creased. Dust jackets/supplements are not included. Stock photo provided. Product includes identifying sticker. Better World Books: Buy Books. Do Good.

Verlag: Performance Programme Dated Saturday 18th March . 2000., 2000
Anbieter: Little Stour Books PBFA Member, Canterbury, Vereinigtes KönigreichLittle Stour Books PBFA Member
Verkäufer/-in kontaktierenVerkäufer/-in mit 5 SternenVerbandsmitglied: PBFA
Zustand: Gebraucht - Sehr gut
EUR 9,88
EUR 35,96 VersandVersand von Vereinigtes Königreich nach USAAnzahl: 1 verfügbar
In den WarenkorbZustand: Fine. Original stapled illustrated souvenir programme. 8½'' x 6''. Contains 24 pages. In Fine condition. Member of the P.B.F.A. MUSIC [Classical].

Verlag: Performance Programme Dated Saturday 2nd March . 2002., 2002
Anbieter: Little Stour Books PBFA Member, Canterbury, Vereinigtes KönigreichLittle Stour Books PBFA Member
Verkäufer/-in kontaktierenVerkäufer/-in mit 5 SternenVerbandsmitglied: PBFA
Zustand: Gebraucht - Sehr gut
EUR 9,88
EUR 35,96 VersandVersand von Vereinigtes Königreich nach USAAnzahl: 1 verfügbar
In den WarenkorbZustand: Fine. Original stapled illustrated souvenir programme. 8½'' x 6''. Contains 24 pages. In Fine condition. Member of the P.B.F.A. MUSIC [Classical].

Verlag: Performance Programme Dated Saturday 2nd March . 2002., 2002
Anbieter: Little Stour Books PBFA Member, Canterbury, Vereinigtes KönigreichLittle Stour Books PBFA Member
Verkäufer/-in kontaktierenVerkäufer/-in mit 5 SternenVerbandsmitglied: PBFA
Zustand: Gebraucht - Sehr gut
EUR 9,88
EUR 35,96 VersandVersand von Vereinigtes Königreich nach USAAnzahl: 1 verfügbar
In den WarenkorbZustand: Fine. Original stapled illustrated souvenir programme. 8½'' x 6''. Contains 24 pages. In Fine condition. Member of the P.B.F.A. MUSIC [Classical].

Verlag: Performance Programme Dated Saturday 12th March . 1994., 1994
Anbieter: Little Stour Books PBFA Member, Canterbury, Vereinigtes KönigreichLittle Stour Books PBFA Member
Verkäufer/-in kontaktierenVerkäufer/-in mit 5 SternenVerbandsmitglied: PBFA
Zustand: Gebraucht - Sehr gut
EUR 9,88
EUR 35,96 VersandVersand von Vereinigtes Königreich nach USAAnzahl: 1 verfügbar
In den WarenkorbZustand: Fine. Original stapled illustrated souvenir programme. 8½'' x 5½''. Contains 20 pages. In Fine condition. Member of the P.B.F.A. MUSIC [Classical].

- Hardcover
Anbieter: GreatBookPricesUK, Woodford Green, Vereinigtes KönigreichGreatBookPricesUK
Verkäufer/-in kontaktierenVerkäufer/-in mit 5 SternenZustand: Neu
EUR 128,51
EUR 17,98 VersandVersand von Vereinigtes Königreich nach USAAnzahl: Mehr als 20 verfügbar
Zustand: New.

- Hardcover
Anbieter: Rarewaves USA, HEBRON, KY, USARarewaves USA
Verkäufer/-in kontaktierenVerkäufer/-in mit 5 SternenZustand: Neu
EUR 153,01
Versand gratisVersand innerhalb von USAAnzahl: Mehr als 20 verfügbar
Hardback. Zustand: New. This book will present contributions by economists, systems developers, safety, health services, occupational and environmental health, and biomedical researchers in the fields of regulatory development, safety, quality assurance, health outcomes, occupational health, and biomedicine. The contributing research will explore the synergy of new science-based risk regulatory approaches, industry focus on manufacturing efficiencies and information technology and biogenetic innovations, and consumers demand for improved safety and quality of products, services, quality assurance, and transparency of information.The book investigates the impact of information technology, biogenetic, and pharmacological innovation on individuals quality of life, safety, individual and system health care utilization, occupational and environmental health and formulary decision making, and costs. It contains analyses of clinical and health outcomes resulting from innovative biopharmaceutical entities and delivery systems in the treatment of chronic conditions. It emphasises effective quality, regulatory system, and consistent science-based decision-making practices from private and public organizations and demonstrates regulatory issues affecting innovation and efficiency.…

- Hardcover
Anbieter: Ria Christie Collections, Uxbridge, Vereinigtes KönigreichRia Christie Collections
Verkäufer/-in kontaktierenVerkäufer/-in mit 5 SternenZustand: Neu
EUR 136,46
EUR 15,38 VersandVersand von Vereinigtes Königreich nach USAAnzahl: Mehr als 20 verfügbar
Zustand: New. In English.

- Hardcover
Anbieter: Rarewaves.com USA, London, LONDO, Vereinigtes KönigreichRarewaves.com USA
Verkäufer/-in kontaktierenVerkäufer/-in mit 5 SternenZustand: Neu
EUR 160,87
Versand gratisVersand von Vereinigtes Königreich nach USAAnzahl: Mehr als 20 verfügbar
Hardback. Zustand: New. This book will present contributions by economists, systems developers, safety, health services, occupational and environmental health, and biomedical researchers in the fields of regulatory development, safety, quality assurance, health outcomes, occupational health, and biomedicine. The contributing research will explore the synergy of new science-based risk regulatory approaches, industry focus on manufacturing efficiencies and information technology and biogenetic innovations, and consumers demand for improved safety and quality of products, services, quality assurance, and transparency of information.The book investigates the impact of information technology, biogenetic, and pharmacological innovation on individuals quality of life, safety, individual and system health care utilization, occupational and environmental health and formulary decision making, and costs. It contains analyses of clinical and health outcomes resulting from innovative biopharmaceutical entities and delivery systems in the treatment of chronic conditions. It emphasises effective quality, regulatory system, and consistent science-based decision-making practices from private and public organizations and demonstrates regulatory issues affecting innovation and efficiency.…

- Hardcover
Anbieter: GreatBookPricesUK, Woodford Green, Vereinigtes KönigreichGreatBookPricesUK
Verkäufer/-in kontaktierenVerkäufer/-in mit 5 SternenZustand: Gebraucht - Wie neu
EUR 165,45
EUR 17,98 VersandVersand von Vereinigtes Königreich nach USAAnzahl: Mehr als 20 verfügbar
Zustand: As New. Unread book in perfect condition.

- Hardcover
Anbieter: Rarewaves USA United, HEBRON, KY, USARarewaves USA United
Verkäufer/-in kontaktierenVerkäufer/-in mit 5 SternenZustand: Neu
EUR 156,90
EUR 45,46 VersandVersand innerhalb von USAAnzahl: Mehr als 20 verfügbar
Hardback. Zustand: New. This book will present contributions by economists, systems developers, safety, health services, occupational and environmental health, and biomedical researchers in the fields of regulatory development, safety, quality assurance, health outcomes, occupational health, and biomedicine. The contributing research will explore the synergy of new science-based risk regulatory approaches, industry focus on manufacturing efficiencies and information technology and biogenetic innovations, and consumers demand for improved safety and quality of products, services, quality assurance, and transparency of information.The book investigates the impact of information technology, biogenetic, and pharmacological innovation on individuals quality of life, safety, individual and system health care utilization, occupational and environmental health and formulary decision making, and costs. It contains analyses of clinical and health outcomes resulting from innovative biopharmaceutical entities and delivery systems in the treatment of chronic conditions. It emphasises effective quality, regulatory system, and consistent science-based decision-making practices from private and public organizations and demonstrates regulatory issues affecting innovation and efficiency.…

- Hardcover
Anbieter: Majestic Books, Hounslow, Vereinigtes KönigreichMajestic Books
Verkäufer/-in kontaktierenVerkäufer/-in mit 4 SternenZustand: Neu
EUR 220,31
EUR 7,79 VersandVersand von Vereinigtes Königreich nach USAAnzahl: 1 verfügbar
Zustand: New. pp. 250.

- Hardcover
Anbieter: Revaluation Books, Exeter, Vereinigtes KönigreichRevaluation Books
Verkäufer/-in kontaktierenVerkäufer/-in mit 5 SternenZustand: Neu
EUR 216,16
EUR 11,99 VersandVersand von Vereinigtes Königreich nach USAAnzahl: 2 verfügbar
Hardcover. Zustand: Brand New. 250 pages. 9.25x6.25x1.25 inches. In Stock.

- Hardcover
Anbieter: Rarewaves USA, HEBRON, KY, USARarewaves USA
Verkäufer/-in kontaktierenVerkäufer/-in mit 5 SternenZustand: Neu
EUR 232,37
Versand gratisVersand innerhalb von USAAnzahl: Mehr als 20 verfügbar
Hardback. Zustand: New. Public health has, for many years, been concerned with efforts to increase the efficiency of health care delivery, to measure changes in health care resource utilization and associated costs, and to link these changes to different types of interventions. These efforts, as well as collaboration between biopharmaceutical organizations, producers of medical devices, and managed care and public health organizations, have been enhanced by the opportunities created within the fast growing field of outcomes research. This volume presents studies contributing to the enhancement of the outcomes research paradigm by incorporating economic and social interactions within the health care delivery, clinical decision-making and outcomes systems. A multidisciplinary team of scientists in the fields of outcomes research, pharmacoeconomics, public health, health services research, and health economics address such complex problems as: benefits and cost of advancements in genetic technologies; methodologies for constructing health care utilization and cost estimates; and the effect of insurance type on resource utilization and health outcomes. Other studies consider both the types of drugs purchased and the prices paid, pharmaceutical spending and health outcomes, incremental advantages of newer treatments, willingness to pay measurements, disease-specific impacts on human capital and quality of life, and modelling clinical trial results. One of the most important findings in this book is the description of the role of low energy in the symptomatology of depression and its strong relationship with absenteeism, work productivity and social functioning. Another paper documents the disease-specific mortality, case-fatality and annual health care utilization in diabetics and establishes the association of respiratory conditions with elevated mortality among diabetics. The work contains other papers which provide significant results in cardiovascular, infectious, central nervous system disease areas as well as in quality of life and health outcomes measurements.…

- Hardcover
Anbieter: Rarewaves.com UK, London, Vereinigtes KönigreichRarewaves.com UK
Verkäufer/-in kontaktierenVerkäufer/-in mit 5 SternenZustand: Neu
EUR 156,88
EUR 77,92 VersandVersand von Vereinigtes Königreich nach USAAnzahl: Mehr als 20 verfügbar
Hardback. Zustand: New. This book will present contributions by economists, systems developers, safety, health services, occupational and environmental health, and biomedical researchers in the fields of regulatory development, safety, quality assurance, health outcomes, occupational health, and biomedicine. The contributing research will explore the synergy of new science-based risk regulatory approaches, industry focus on manufacturing efficiencies and information technology and biogenetic innovations, and consumers demand for improved safety and quality of products, services, quality assurance, and transparency of information.The book investigates the impact of information technology, biogenetic, and pharmacological innovation on individuals quality of life, safety, individual and system health care utilization, occupational and environmental health and formulary decision making, and costs. It contains analyses of clinical and health outcomes resulting from innovative biopharmaceutical entities and delivery systems in the treatment of chronic conditions. It emphasises effective quality, regulatory system, and consistent science-based decision-making practices from private and public organizations and demonstrates regulatory issues affecting innovation and efficiency.…

- Hardcover
Anbieter: Home-set, Mannheim, DeutschlandHome-set
Verkäufer/-in kontaktierenVerkäufer/-in mit 5 SternenZustand: Neu
EUR 192,88
EUR 49,90 VersandVersand von Deutschland nach USAAnzahl: 2 verfügbar
Gebundene Ausgabe. Zustand: Neu. Investigates the impact of information technology, biogenetic, and pharmacological innovation on individuals quality of life, safety, individual and system health care utilization, occupational and environmental health and formulary decision making, and costs. Sprache: Englisch Gewicht in Gramm: 748. …